| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.18B | 135.45B | 133.59B | 128.07B | 134.30B | 114.50B |
| Gross Profit | 27.29B | 28.01B | 28.03B | 27.39B | 27.59B | 25.04B |
| EBITDA | 5.66B | 3.32B | 5.75B | 5.28B | 5.19B | 5.12B |
| Net Income | 2.11B | 2.13B | 2.08B | 1.85B | 1.65B | 2.20B |
Balance Sheet | ||||||
| Total Assets | 78.26B | 82.99B | 79.43B | 79.27B | 84.20B | 69.55B |
| Cash, Cash Equivalents and Short-Term Investments | 4.88B | 5.37B | 3.96B | 3.83B | 3.09B | 4.54B |
| Total Debt | 26.79B | 29.55B | 26.68B | 20.04B | 29.86B | 22.40B |
| Total Liabilities | 54.89B | 58.40B | 56.19B | 56.48B | 62.95B | 50.21B |
| Stockholders Equity | 23.37B | 24.36B | 23.24B | 22.79B | 21.25B | 19.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -473.00M | -4.74B | 10.85B | -7.25B | -4.76B |
| Operating Cash Flow | 0.00 | 897.00M | -2.88B | 12.47B | -3.65B | -1.63B |
| Investing Cash Flow | 0.00 | -1.25B | -1.83B | -2.17B | -3.96B | -4.01B |
| Financing Cash Flow | 0.00 | 1.31B | 4.86B | -9.48B | 6.16B | 4.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥132.55B | 13.36 | ― | 3.43% | 0.61% | 8.76% | |
63 Neutral | ¥128.05B | 9.15 | ― | 2.85% | 3.66% | -12.27% | |
62 Neutral | ¥171.98B | 10.80 | ― | 1.58% | 1.63% | 7.24% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥26.21B | 9.94 | ― | 1.66% | 1.39% | 6.27% | |
54 Neutral | ¥204.43B | 12.26 | ― | 2.83% | -0.42% | -0.30% | |
52 Neutral | ¥59.84B | 231.28 | 0.36% | 2.78% | -3.62% | 146.18% |